Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 6/18/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Michael Friedman?

Michael A. Friedman

Commissioner

Food and Drug Administration

Email: m***@***.gov

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Food and Drug Administration

Background Information

Employment History

President and Chief Executive Officer

City of Hope incorporated


Professor of Otolaryngology

Rush University Medical Center


Chairman of Otolaryngology - Head and Neck Surgery

Advocate Christ Medical Center


Medical Director

Chicago ENT


Senior Vice President of Research and Development, Medical and Public Policy

Pharmacia Corporation


Affiliations

MannKind Corporation

Board Member


Celgene Corporation

Board Member


Project Extreme

BOARD OF GOVERNORS Member


American Academy of Otolaryngology - Head and Neck Surgery , Inc.

Sleep Disorders Committee


Zelegent Inc

Clinical Advisory Board Member


Governance Committee

Independent Director, Member of Compensation Committee, Committee Chair


Smith & Nephew Inc

Board Member


Rite Aid Corporation

Board Member


Tulane University

Board of Trustees


STOP CANCER

Advisory Board Member


Independent Citizens' Oversight Committee

Member, Oversight Committee


American Sleep Disorders Association

Member


Clinical Sleep Society

Member


California Healthcare Institute Inc

Board Member


Tulane University

Board Member


Daily Stocks

Member of the Nominating Committee of Board of Directors


California Institute for Regenerative Medicine

Independent Citizens' Oversight Committee


ALMAC GROUP LTD

Scientific Advisory Board Member


Cellgate Inc.

Scientific Advisory Board Member


SinuCare Inc

Medical Advisory Board Member


American Society of Clinical Oncology

Chair of the Research Committee


ArraDx Limited

Member of Scientific Advisory Board


Armed Forces Institute of Pathology

Board of Governors


Prop 71

Member of Stem Cell Oversight Committee


Government Reform and Oversight , Subcommittee on Human Resources and Intergovernmental Relations

Deputy Commissioner for Operations, House Committee


Education

American Academy of Otolaryngology - Head and Neck Surgery


B.A. degree

University of South Florida


Doctorate in Medicine

University of Texas Southwestern Medical Center


M.D.

The California Healthcare Institute


MD

Salk Institute for Biological Studies


MPH


MPH degree

University of South Florida


bachelor's degree

Tulane University


bachelor's degree

University of Michigan


doctorate in Medicine

University of Texas Southwestern Medical School


master's degree

University of Michigan


Web References(151 Total References)


MannKind Corporation - Board of Directors

investors.mannkindcorp.com [cached]

Michael Friedman M.D.
Director Michael A. Friedman, M.D. has been one of our directors since December 2003. In 2014, Dr. Friedman completed a decade of service as the President and Chief Executive Officer of the City of Hope National Medical Center. Previously, from September 2001 until April 2003, Dr. Friedman held the position of Senior Vice President of Research and Development, Medical and Public Policy, for Pharmacia Corporation and, from July 1999 until September 2001, was a senior vice president of Searle, a subsidiary of Monsanto Company. From 1995 until June 1999, Dr. Friedman served as Deputy Commissioner for Operations for the Food and Drug Administration, and was Acting Commissioner and Lead Deputy Commissioner from 1997 to 1998. He joined the board of Celgene Corporation in February 2011 and the board of Smith & Nephew plc in April 2013. Dr. Friedman received a Bachelor of Arts degree, magna cum laude, from Tulane University, New Orleans, Louisiana, and a doctorate in medicine from the University of Texas, Southwestern Medical School.


Board of Directors and Committees | Celgene

www.celgene.com [cached]

Michael A. Friedman, M.D.
Emeritus Chief Executive Officer, City of Hope Michael A. Friedman , M.D . has served as one of our directors since February 2011 and a member of the Nominating Committee since April 2011. Dr. Friedman is the emeritus Chief Executive Officer of City of Hope, a leading cancer research, treatment and education institution, as well as Director of the organization's Comprehensive Cancer Center and holder of the Irell & Manella Cancer Center Director's Distinguished Chair. Before leading City of Hope, Dr. Friedman was Senior Vice President of Research and Development, Medical and Public Policy for Pharmacia Corporation and Chief Medical Officer for biomedical preparedness at PhRMA. Additionally, Dr. Friedman previously served as Deputy Commissioner for the U.S. Food and Drug Administration (FDA), later serving as Acting Commissioner, and as Associate Director of the National Cancer Institute, National Institutes of Health. Since 2004, Dr. Friedman serves on the Independent Citizens' Oversight Committee which governs the California Institute for Regenerative Medicine and oversees the implementation of California's stem cell research effort. Dr. Friedman is a member of the Board of Directors of MannKind Corporation and Smith & Nephew plc. He also serves on the Board of Trustees for Tulane University and the California State Stem Cell Initiative. Dr. Friedman brings to his service as a director valuable scientific and operational expertise and leadership skills from his extensive background in cancer research and public health as a senior officer of a leading research institution, deputy and acting commissioner of the FDA, and as an executive officer of a major pharmaceutical company.


www.sec.gov

Michael A. Friedman, M.D.(1)(2)
Michael A. Friedman, M.D. has been one of our directors since December 2003. In 2014, Dr. Friedman completed a decade of service as the President and Chief Executive Officer of the City of Hope National Medical Center. Previously, from September 2001 until April 2003, Dr. Friedman held the position of Senior Vice President of Research and Development, Medical and Public Policy, for Pharmacia Corporation and, from July 1999 until September 2001, was a senior vice president of Searle, a subsidiary of Monsanto Company. From 1995 until June 1999, Dr. Friedman served as Deputy Commissioner for Operations for the Food and Drug Administration, and was Acting Commissioner and Lead Deputy Commissioner from 1997 to 1998. He joined the board of Celgene Corporation in February 2011 and the board of Smith & Nephew plc in April 2013. Dr. Friedman received a bachelor of arts degree, magna cum laude, from Tulane University, New Orleans, Louisiana, and a doctorate in medicine from the University of Texas, Southwestern Medical School. The Board believes Dr. Friedman’s business experience, including his experience as an executive officer at biopharmaceutical companies and a leading clinical and research center specializing in cancer and diabetes, and his service at the Food and Drug Administration, combined with his business acumen and judgment provide our Board with valuable scientific and operational expertise and leadership skills.


www.smithandnephew.com

9. To re-elect Michael Friedman as a Director of the Company.
Michael Friedman (70) Michael Friedman, Independent Non-executive Director. Michael joined the Board and was appointed and elected by shareholders at the Annual General Meeting on 11 April 2013. He is a member of the Ethics & Compliance Committee. Michael was formerly Chief Executive Officer of City of Hope, the prestigious cancer research and treatment institute in California and is now Executive for Special Projects and Emeritus Cancer Center Director. He has also served as Director of the institution's comprehensive cancer centre and held the Irell & Manella Cancer Center Director's Distinguished Chair. He was formerly senior vice president of research, medical and public policy for Pharmacia Corporation and has served as Deputy Commissioner and Acting Commissioner at the US Food and Drug Administration. He has also served on a number of Boards in a Non-executive capacity, including RiteAid Corporation. He is also Non-executive Director of Celgene Corporation and Mannkind Corporation.


www.sec.gov

Michael A. Friedman, M.D.(1)(2)
Michael A. Friedman, M.D. has been one of our directors since December 2003. In 2014, Dr. Friedman completed a decade of service as the President and Chief Executive Officer of the City of Hope National Medical Center. Previously, from September 2001 until April 2003, Dr. Friedman held the position of Senior Vice President of Research and Development, Medical and Public Policy, for Pharmacia Corporation and, from July 1999 until September 2001, was a senior vice president of Searle, a subsidiary of Monsanto Company. From 1995 until June 1999, Dr. Friedman served as Deputy Commissioner for Operations for the Food and Drug Administration, and was Acting Commissioner and Lead Deputy Commissioner from 1997 to 1998. He joined the board of Celgene Corporation in February 2011 and the board of Smith & Nephew plc in April 2013. Dr. Friedman received a bachelor of arts degree, magna cum laude, from Tulane University, New Orleans, Louisiana, and a doctorate in medicine from the University of Texas, Southwestern Medical School. The Board believes Dr. Friedman’s business experience, including his experience as an executive officer at biopharmaceutical companies and a leading clinical and research center specializing in cancer and diabetes, and his service at the Food and Drug Administration, combined with his business acumen and judgment provide our Board with valuable scientific and operational expertise and leadership skills.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory